Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.

British journal of neurosurgery - 1 Aug 2009

Pizer Barry L, Clifford Steven C

Abstract excerpt

Medulloblastoma is the most common malignant brain tumour of childhood and accounts for around 10% of all childhood cancer deaths. Despite recent improvements in survival rates, the delivery of individualised therapies based on disease-risk remains a major goal; intensified treatment for poor-ris...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cerebellar Neoplasms
Share to Clinical Trials as Topic
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Feasibility Studies

Share to Intercellular Signaling Peptides and Proteins

Share to Medulloblastoma

Share to Patient Selection

Share to Survival Rate

Source

Identifiers

PMID: 19637007
DOI: 10.1080/02688690903121807

Genes

MYC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19637007-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.PMID 19637007Read ↗

Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic InsightsSemantic proximity Read ↗

Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a TimeSemantic proximity Read ↗

Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics.Semantic proximity Read ↗

Medulloblastoma: what is the role of molecular genetics?Semantic proximity Read ↗

Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis ParadigmSemantic proximity Read ↗

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).Semantic proximity Read ↗

New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.Semantic proximity Read ↗

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.Semantic proximity Read ↗

Medulloblastoma: From TP53 Mutations to Molecular Classification and Liquid BiopsySemantic proximity Read ↗

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.Semantic proximity Read ↗

The molecular classification of medulloblastomaSemantic proximity Read ↗

[Evolution of the management of pediatric and adult medulloblastoma].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.